These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2415549)

  • 21. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Variation of the thyrotropin-releasing-hormone (TRH) stimulated thyrotropin (TSH) response in comparison with the tyhroid-gland-suppression test and the triiodothyronine (T3) and thyroxine (T4) blood levels in the so-called euthyroid endocrine ophthalmopathy].
    Wenzel KW
    Endokrinologie; 1975 Sep; 66(1):67-73. PubMed ID: 1243821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship among thyrotropin (TSH), thyroid stimulating immunoglobulins, and results of triiodothyronine (T3) suppression test in patients with Graves' disease.
    Horimoto M; Nishikawa M; Uno C; Yoshikawa N; Taniguchi N; Inada M
    Endocrinol Jpn; 1988 Dec; 35(6):841-8. PubMed ID: 2471633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in thyroid functions in patients with euthyroid Graves' disease.
    Tamai H; Nakagawa T; Ohsako N; Fukino O; Takahashi H; Matsuzuka F; Kuma K; Nagataki S
    J Clin Endocrinol Metab; 1980 Jan; 50(1):108-12. PubMed ID: 6765952
    [No Abstract]   [Full Text] [Related]  

  • 27. Thyrotropin-releasing hormone testing during antithyroid drug treatment of Graves' disease as an indicator of remission.
    Dahlberg PA; Karlsson FA; Jansson R; Wide L
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1100-4. PubMed ID: 2414311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.
    Wenzel KW; Lente JR
    J Clin Endocrinol Metab; 1984 Jan; 58(1):62-9. PubMed ID: 6196375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of relapse in Graves' disease.
    Nagataki S
    Ann Acad Med Singap; 1986 Oct; 15(4):486-91. PubMed ID: 2436562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of simultaneous T3, T4, and TSH measurements for management of graves' disease in children.
    Golden MP; Kaplan SA; Lippe BM; Lee WN
    Pediatrics; 1977 May; 59(5):762-7. PubMed ID: 577011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status.
    Momotani N; Noh J; Oyanagi H; Ishikawa N; Ito K
    N Engl J Med; 1986 Jul; 315(1):24-8. PubMed ID: 2423874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
    Brokken LJ; Wiersinga WM; Prummel MF
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective cohort study: do patients with graves' disease need to be euthyroid prior to surgery?
    Al Jassim A; Wallace T; Bouhabel S; Majdan A; Hier M; Forest VI; Payne R
    J Otolaryngol Head Neck Surg; 2018 May; 47(1):37. PubMed ID: 29784035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
    Tamai H; Hayaki I; Kawai K; Komaki G; Matsubayashi S; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1995 May; 80(5):1481-4. PubMed ID: 7744989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum thyroglobulin concentration as an indicator for assessing thyroid stimulation in patients with Graves' disease during antithyroid drug therapy.
    Aizawa T; Ishihara M; Koizumi Y; Hashizume K; Takasu N; Yamada T; Kobayashi I; Watanabe T; Shimizu Z
    Am J Med; 1990 Aug; 89(2):175-80. PubMed ID: 2166430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effects of corticosteroids on thyroid activity in Graves' disease.
    Williams DE; Chopra IJ; Orgiazzi J; Solomon DH
    J Clin Endocrinol Metab; 1975 Aug; 41(2):354-61. PubMed ID: 1174132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.